Endometrial hyperplasia without atypia
Information
- Disease name
- Endometrial hyperplasia without atypia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01685762 | Completed | Early Phase 1 | Metformin for the Treatment of Endometrial Hyperplasia | January 10, 2013 | December 1, 2015 |
| NCT03675139 | Completed | Phase 3 | MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia | February 26, 2019 | May 15, 2022 |
| NCT03992937 | Completed | N/A | Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia | June 20, 2019 | December 1, 2020 |
| NCT06115577 | Completed | Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes | October 1, 2012 | August 1, 2022 | |
| NCT06378489 | Not yet recruiting | The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study | June 1, 2024 | May 31, 2025 |